| Kathleen Derrig True, LCSW | |
|
22 W Cole Rd Ste 103, Biddeford, ME 04005-9431 | |
| (207) 571-9923 | |
| Not Available |
| Full Name | Kathleen Derrig True |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 22 W Cole Rd Ste 103, Biddeford, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174149793 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | MC18493 (Maine) | Secondary |
| 1041C0700X | Social Worker - Clinical | LC21977 (Maine) | Primary |
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Healthy adults who have a good constitution and have a healthy heart are being called forth to donate samples of their faeces to science. The donors would be screened rigorously before they can be included and would be compensated modestly for their donations say researchers.
More than $9 million in federal grants will help fund researchers in the Ohio State University Davis Heart and Lung Research Institute and their collaborators across the university campus to investigate new causes and treatments for cardiovascular disease.
Point-of-care testing with screen-printed electrodes allows rapid testing of populations for viral outbreaks – at affordable costs, without the need for trained specialists and/or complicated equipment.
Edge Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing life-saving hospital products for acute, fatal or debilitating conditions, announced today that the U.S. Food and Drug Administration has accepted the Company's Investigational New Drug application for EG-1962, a novel bio-absorbable nimodipine microparticle formulation.
In a study to be presented on Feb. 6 at 9 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that noninvasive prenatal testing detected 83.2 percent of chromosomal abnormalities normally picked up by invasive diagnostic testing strategies, such as chorionic villus sampling (CVS) or amniocentesis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Derrig True, LCSW 123 Andover Rd, Westbrook, ME 04092-3850 Ph: (207) 761-2200 | Kathleen Derrig True, LCSW 22 W Cole Rd Ste 103, Biddeford, ME 04005-9431 Ph: (207) 571-9923 |
News Archive
Healthy adults who have a good constitution and have a healthy heart are being called forth to donate samples of their faeces to science. The donors would be screened rigorously before they can be included and would be compensated modestly for their donations say researchers.
More than $9 million in federal grants will help fund researchers in the Ohio State University Davis Heart and Lung Research Institute and their collaborators across the university campus to investigate new causes and treatments for cardiovascular disease.
Point-of-care testing with screen-printed electrodes allows rapid testing of populations for viral outbreaks – at affordable costs, without the need for trained specialists and/or complicated equipment.
Edge Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing life-saving hospital products for acute, fatal or debilitating conditions, announced today that the U.S. Food and Drug Administration has accepted the Company's Investigational New Drug application for EG-1962, a novel bio-absorbable nimodipine microparticle formulation.
In a study to be presented on Feb. 6 at 9 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that noninvasive prenatal testing detected 83.2 percent of chromosomal abnormalities normally picked up by invasive diagnostic testing strategies, such as chorionic villus sampling (CVS) or amniocentesis.
› Verified 4 days ago
Daniela Mason, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2 Springbrook Dr, Biddeford, ME 04005 Phone: 207-282-1500 Fax: 207-282-2581 | |
Mr. Matthew Edward Wells, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2 Springbrook Dr, Biddeford, ME 04005 Phone: 207-282-1500 Fax: 207-282-2581 | |
Lynn I Watson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10 May St, Biddeford, ME 04005 Phone: 207-205-2560 Fax: 207-284-7861 | |
Ms. Virginia Deluca, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 497 Elm St, Biddeford, ME 04005 Phone: 180-045-5872 | |
Amber L Silva, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24 State St Apt 37, Biddeford, ME 04005 Phone: 207-922-4600 Fax: 207-294-4649 | |
Timothy Fuller, LMSW-CC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 314 Alfred St, Biddeford, ME 04005 Phone: 207-216-2637 | |
Ms. Patricia A Burke, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 411 Alfred St, Biddeford, ME 04005 Phone: 207-625-7012 |